Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Treatment of infantile-onset spinal muscular atrophy with nusinersen: final report of a phase 2, open-label, multicentre, dose-escalation study.
Journal: The Lancet. Child & adolescent health
Published: January 18, 2021
Safety and efficacy of nusinersen in spinal muscular atrophy: The EMBRACE study.
Journal: Muscle & nerve
Published: August 28, 2020
Showing 1-2 of 2
Last Updated: 09/26/2026